Celogos was founded in 2001 and was initially incubated by the Pasteur Institute in Paris. Since inception in 2001, the company has been working on the development of an innovative technology platform called RCD (Rational Cell Design). This patented platform has been applied to the discovery, optimisation, production and delivery of new cell therapy products. RCD constitutes the key building block of the company's strategic plan to provide innovative and efficient solutions for a large panel of muscular diseases. In 2005, in an effort to successfully develop the Celogos technological platform to its utmost potential, the company entered into an alliance with Laboratoire HRA Pharma, a France-based specialty pharmaceutical company ( www.hra-pharma.com). This alliance associates Celogos's strong scientific know-how in muscle regeneration with HRA Pharma's clinical development and business expertise in pharmaceutical field.Today, HRA Pharma owns a majority stake in Celogos.
| Website | http://www.celogos.fr |
| Revenue | $2 million |
| Employees | View employees |
| Address | 15 Rue Béranger, Paris, Ile-de-France 75003, FR |
| Phone | +33 1 40 33 66 06 |
| Industry | Business Services General, Business Services |
| Competitors | Accenture, Capgemini, Atos Consulting, Orange Business, Sopra Steria, Devoteam, Bouygues Telecom, Talan, Aricent, OPEN +42 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies |
Looking for a particular Celogos employee's phone or email?
Celogos Questions
The Celogos annual revenue was $2 million in 2026.
Celogos is based in Paris, Ile-de-France.
The NAICS codes for Celogos are [5417, 54171, 54, 541713, 541].
The SIC codes for Celogos are [87, 873].
